Skip to main content
HR 2297 118th Congress House Health

To provide for a limitation on availability of funds for Related Agency and Food and Drug Administration, FDA Innovation Account, Cures Act for fiscal year 2024.

Introduced: March 29, 2023 Introduced by: Biggs, Andy Republican · Arizona See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 7, 2023
Referred to the Subcommittee on Health.
Mar 29, 2023
Referred to the House Committee on Energy and Commerce.
Mar 29, 2023
Introduced in House
 Plain-English summary Congressional Research Service

This bill limits FY2024 funding for the Food and Drug Administration (FDA) Innovation Account, which the FDA uses to implement provisions of the 21st Century Cures Act relating to the development of medical products.

What's happening now April 7, 2023

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2
 Cosponsors 1
All 1 Republican 1